Litigation Details for JAZZ PHARMACEUTICALS IRELAND LIMITED v. TEVA PHARMACEUTICALS, INC. (D.N.J. 2023)
JAZZ PHARMACEUTICALS IRELAND LIMITED v. TEVA PHARMACEUTICALS, INC. (D.N.J. 2023)
| Docket | ⤷ Start Trial | Date Filed | 2023-03-21 |
| Court | District Court, D. New Jersey | Date Terminated | 2023-12-15 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Jessica S. Allen |
| Patents | 10,195,168; 10,213,400; 10,675,258; 10,864,181; 11,253,494; 11,426,373; 11,554,102; 8,591,922; 8,772,306; 8,901,173; 9,050,302; 9,132,107; 9,486,426 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in JAZZ PHARMACEUTICALS IRELAND LIMITED v. TEVA PHARMACEUTICALS, INC.
The small molecule drugs covered by the patents cited in this case are ⤷ Start Trial and ⤷ Start Trial .
Details for JAZZ PHARMACEUTICALS IRELAND LIMITED v. TEVA PHARMACEUTICALS, INC. (D.N.J. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-03-21 | External link to document | |||
| 2023-03-21 | 1 | Complaint | the ’107 patent”); 9,486,426 (“the ’426 patent”); 10,195,168 (“the ’168 patent”); 10,213,400 (“the ’400…27 PageID: 2 patent”); 8,901,173 (“the ’173 patent”); 9,050,302 (“the ’302 patent”); 9,132,107 (“the…400 patent”); 10,675,258 (“the ’258 patent”); 10,864,181 (“the ’181 patent”); 11,253,494 (“the ’494 … patent”); 11,426,373 (“the ’373 patent”); and 11,554,102 (“the ’102 patent”) (collectively, “the patents-in-suit… This complaint is an action for patent infringement under the patent laws of the United States, 35 U.S.C | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
